Articles

• Oligomer-specific A? toxicity in cell models is mediated by selective uptake.
  S.M. Chafekar, F. Baas and W. Scheper (2008a).
  Biochimica et biophysica acta 2008;1782(9):523-31;
  http://dx.doi.org/10.1016/j.bbadis.2008.06.003
• Increased A?1-42 production sensitizes neuroblastoma cells for ER stress toxicity.
  S.M. Chafekar, R. Zwart, R. Veerhuis, H. Vanderstichele, F. Baas and W. Scheper
  Current Alzheimer research 2008;5:469-74;
  http://www.ncbi.nlm.nih.gov/pubmed/18855588?dopt=Citation
• Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCI.
  Pieter Jelle Visser and David S. Knopman.
  Neurology 2009;73;744-745;
  http://www.neurology.org/cgi/content/full/73/10/744
• Meta-analysis of CSF biomarkers as predictor for conversion from mild cognitive impairment to Alzheimer's disease.
  Stephanie Vos, Frans Verhey, Lyzel S. Elias-Sonnenschein, Pieter Jelle Visser.
  Alzheimer's & Dementia 2010; 6:S521-522.
  http://www.alzheimersanddementia.com/article/S1552-5260(10)01858-3/fulltext

Conference abstracts

• Endoplasmic reticulum stress in Alzheimer's disease.
  Wiep Scheper, Sidhartha M. Chafekar, María López-Cavanillas, Rob Zwart, Jeroen J.M. Hoozemans, Frank Baas.
  Alzheimer's & Dementia 2008; 4: T644;
  http://dx.doi.org/10.1016/j.jalz.2008.05.1988
• New prospects in CNS biomarker detection.
  Ron Wacker, Joachim Dyck, Andreas Jonas, and Michael Adler.
  Neurodegenerative Dis 2007; 4(suppl 1): 146
  http://www.chimera-biotec.com/data/pdf/Chimera_ADPD_2007.pdf
• High sensitive CNS biomarker detection.
  Ron Wacker, Michael Adler.
  Alzheimer's & Dementia 2008; 4: T336-37;
  http://dx.doi.org/doi:10.1016/j.jalz.2008.05.981
• A highly sensitive assay for detection of A? aggregates in body fluids: A method for early diagnosis of Alzheimer's disease?
  Susanne A. Funke, Lei Wang, Pia Zißmann, Eva Birkmann, Phillip Görtz, Christian Lange-Asschenfeldt, Dieter Willbold
  Alzheimer's & Dementia July 2010; 6:S159
  http://www.alzheimersanddementia.com/article/S1552-5260(10)00616-3/fulltext
• Cognitive function and cognitive change in dementia, mild cognitive impairment, and healthy aging: The EDAR study.
  Jennifer H. Barnett, Andrew Blackwell, Philip Scheltens, Gunhild Waldemar, Peter Johannsen, Magda Tsolaki, Rik Vandenberghe, Lars-Olof Wahlund, Frans Verhey, Pieter Jelle Visser.
  Alzheimer's & Dementia July 2010; 6: S127
  http://www.alzheimersanddementia.com/article/S1552-5260(10)00519-4
• Predictors for Alzheimer's disease in the non-demented subjects: Results from the DESCRIPA study
  Pieter Jelle Visser
  Alzheimer's & Dementia 2010; 6:S63
  http://www.alzheimersanddementia.com/article/S1552-5260(10)00301-8/fulltext
• CSF markers as predictors for Alzheimer's disease in subjects with MCI: Effect of APOE genotype-adjusted cut offs.
  Leah Burns, Ineke van Rossum, Pablo Lapuerta, Frans Verhey, Wiesje van der Flier, Lars-Olof Wahlund, Magda Tsolaki, Lennart Minthon, Katharina Buerger, Harald Hampel, Tuula Pirtilla, Hilkka Soininen, Marcel Verbeek, Luiza Spiru, Marinus Blankenstein, Kaj Blennow, Philip Scheltens, Pieter Jelle Visser.
  Alzheimer's & Dementia 2010; 6:S125
  http://www.alzheimersanddementia.com/article/S1552-5260(10)00513-3/fulltext
• Predictors of time to AD diagnosis in subjects with MCI
  Ineke A. van Rossum, Pieter Jelle Visser, Wiesje M. van der Flier, Marinus A. Blankenstein, and Philip Scheltens.
  Alzheimer's & Dementia 2010; 6:S99;
  http://www.alzheimersanddementia.com/article/S1552-5260(10)00430-9/fulltext